Phase II study of gemcitabine, capecitabine and cisplatin in patients with advanced pancreatic cancer.

被引：0
|
作者：
Chang, HM [1 ]
Kim, TW [1 ]
Ahn, JH [1 ]
Ryu, MH [1 ]
Lee, JS [1 ]
Kim, WK [1 ]
Kang, YK [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4219
引用
下载
收藏
页码：368S / 368S
页数：1
相关论文
共 50 条
  • [21] A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma
    Park, Byeong-Bae
    Park, Joon Oh
    Lee, Hyo Rak
    Lee, Jeeyun
    Choi, Dong Wook
    Choi, Seong-Ho
    Heo, Jin Seok
    Lee, Jong Kyun
    Lee, Kyu Taek
    Lim, Do Hoon
    Park, Young Suk
    Lim, Ho-Yeong
    Kang, Won Ki
    Park, Keunchil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 489 - 494
  • [22] Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer
    Kroep, JR
    Pinedo, HM
    Giaccone, G
    Van Bochove, A
    Peters, GJ
    Van Groeningen, CJ
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 230 - 235
  • [23] Gemcitabine and protracted 5-FU for advanced pancreatic cancer.: A phase II study
    Kurtz, JE
    Kohser, F
    Négrier, S
    Trillet-Lenoir, V
    Walter, S
    Limacher, JM
    Untereiner, M
    Kayitalire, L
    Jaeck, D
    Dufour, P
    HEPATO-GASTROENTEROLOGY, 2000, 47 (35) : 1450 - 1453
  • [24] A phase II study of weekly cisplatin and gemcitabine in patients with advanced pancreatic cancer: Is this a strategy still worth pursuing?
    Clayton, AJ
    Mansoor, AW
    Jones, ET
    Hawkins, RE
    Saunders, MP
    Swindell, R
    Valle, JW
    PANCREAS, 2006, 32 (01) : 51 - 57
  • [25] Bevacizumab plus gemcitabine and capecitabine in patients with advanced pancreatic cancer with ECOG PS 0/1: A phase II study
    Javle, M. M.
    Garrett, C. R.
    Chodkiewicz, C.
    Wallace, P. K.
    Yu, J.
    Pande, A. U.
    Phelan, J. T.
    Litwin, A. M.
    Gibbs, J. F.
    Iyer, R. V.
    ANNALS OF ONCOLOGY, 2006, 17 : 310 - 310
  • [26] Liposomal cisplatin combined with gemcitabine in pretreated advanced pancreatic cancer patients: A phase I-II study
    Stathopoulos, GP
    Boulikas, T
    Vougiouka, M
    Rigatos, SK
    Stathopoulos, JG
    ONCOLOGY REPORTS, 2006, 15 (05) : 1201 - 1204
  • [27] Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer
    Cartwright, TH
    Cohn, A
    Varkey, JA
    Chen, YM
    Szatrowski, TP
    Cox, JV
    Schulz, JJ
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 160 - 164
  • [28] Phase II trial of postoperative adjuvant gemcitabine and cisplatin chemotherapy followed by chemoradiation with gemcitabine in patients with resected pancreatic cancer.
    Kwon, J. H.
    Chie, E. K.
    Kim, J. H.
    Im, S.
    Oh, D.
    Kim, Y.
    Han, S.
    Lee, K.
    Jang, J.
    Kim, T.
    Kim, J. S.
    Han, H. S.
    Kim, S.
    Yoon, Y. B.
    Bang, Y.
    Ha, S. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    Hwang, In Gyu
    Jang, Joung-Soon
    Oh, Sung Yong
    Lee, Suee
    Kwon, Hyuk Chan
    Lee, Gyeong Won
    Go, Seil
    Kang, Myoung Hee
    Cha, Young Joo
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2371 - 2376
  • [30] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    In Gyu Hwang
    Joung-Soon Jang
    Sung Yong Oh
    Suee Lee
    Hyuk Chan Kwon
    Gyeong Won Lee
    Seil Go
    Myoung Hee Kang
    Young Joo Cha
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 2371 - 2376
12345